Test Price
1,500 AEDโ Home Collection Available
Venous Thrombosis Risk Analysis Panel | 1500 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing at our Dubai Healthcare City reference laboratory.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: DHA-Licensed Consultant Medical Genetics telephonic post-test consultation included with every panel.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Venous Thrombosis Risk Analysis Panel uses advanced molecular genetics techniques to detect inherited thrombophilia mutations. By identifying genetic variants such as Factor V Leiden, Prothrombin G20210A, and MTHFR polymorphisms, this panel enables preemptive risk stratification for deep vein thrombosis, pulmonary embolism, and recurrent pregnancy loss. All testing is performed at our CAP-accredited facility in Dubai Healthcare City using validated Real-Time PCR and Whole Genome Sequencing workflows.
| Feature | DNA Labs UAE Panel | Standard Coagulation Assay |
|---|---|---|
| Mutation Coverage | Real-Time PCR & WGS โ detects >15 thrombophilia-associated variants | Protein C/S activity, Antithrombin III โ limited genetic insight |
| Methodology | Molecular Genetics (LC-MS/MS validated, ISO 15189 compliant) | Functional coagulation assays (PT, aPTT, fibrinogen) |
| Turnaround Time | 5 working days from sample receipt | 2โ3 days (faster but phenotype-only) |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh
Consultant Medical Genetics | DHA Registration ID: 9294403
โInherited thrombophilia testing provides powerful risk information, yet it must never replace clinical judgment. A positive genetic finding indicates lifelong susceptibility, but it does not confirm active thrombosis. I counsel every patient to review their results with their treating physician and integrate family history before making anticoagulation decisions. Our genetics team provides a detailed interpretive letter to support that conversation.โ
Medication Safety Advisory
Never stop prescribed anticoagulants or antiplatelet therapy without explicit physician approval. Abrupt discontinuation of warfarin, rivaroxaban, apixaban, or clopidogrel may trigger rebound thrombosis leading to stroke or pulmonary embolism. If you are taking blood thinners and experience unusual bruising, dark urine, or gum bleeding, contact your doctor immediately rather than adjusting your dose.
Clinical Exclusion Criteria
This genetic panel is not appropriate as a standalone diagnostic tool in the following scenarios:
- Active thromboembolic event: Suspected deep vein thrombosis or pulmonary embolism within the past three months requires urgent imaging and acute management, not genetic testing.
- Pregnancy or immediate postpartum period: Gestational physiological changes alter coagulation factor levels and may confound risk interpretation.
- Known coagulopathy unrelated to thrombophilia: Advanced liver disease, disseminated intravascular coagulation, or vitamin K deficiency should be evaluated prior to genetic analysis.
Emergency Red Flags โ Seek Immediate Care If You Experience:
- Unilateral leg swelling with warmth, redness, or tenderness (possible deep vein thrombosis).
- Sudden chest pain, difficulty breathing, or hemoptysis (possible pulmonary embolism).
- Severe headache with vision changes, slurred speech, or unilateral limb weakness (possible stroke).
Patient FAQ & Clinical Guidance
1. What is the Venous Thrombosis Risk Analysis Panel and what does it detect?
This molecular panel identifies inherited genetic variants that increase susceptibility to venous thromboembolism. It specifically screens for Factor V Leiden (G1691A), Prothrombin G20210A, and MTHFR C677T/A1298C polymorphisms, which together account for the majority of hereditary thrombophilia cases. Acquired causes such as antiphospholipid syndrome require separate serologic testing and are not covered by this panel.
2. How should I prepare for the blood collection appointment?
No fasting is required. Continue all prescribed medications unless your doctor instructs otherwise. Maintain normal hydration to facilitate venipuncture. Our mobile phlebotomist collects 5 mL of whole blood in two lavender-top EDTA tubes; specimens are immediately placed under refrigerated transport conditions to preserve nucleic acid integrity for downstream genetic analysis.
3. What happens if a thrombophilia mutation is identified in my sample?
A positive result indicates a lifelong elevated risk for blood clotting events, not a current diagnosis. Our Consultant Medical Genetics will contact you for a telephonic consultation to explain the finding, discuss preventive strategies such as lifestyle modification or prophylactic anticoagulation, and coordinate with your primary care physician. A comprehensive DHA-compliant report with interpretive commentary is provided within five working days.
UAE Regulatory & Data Privacy Adherence
Data Protection & Healthcare Compliance Framework
All genetic data generated by this panel is processed, stored, and transmitted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. No raw genetic information is shared with third parties without explicit written authorization. DNA Labs UAE maintains a dedicated Data Protection Officer and employs AES-256 encryption for all electronic health records.
Clinical & Logistical Metadata
| Test Name | Venous Thrombosis Risk Analysis Panel (Inherited Thrombophilia) |
| Price (AED) | 1,500 AED |
| Turnaround Time | 5 Working Days from Sample Receipt |
| Sample Type / Matrix | Whole Blood (EDTA, 5 mL) |
| Methodology Used | Real-Time PCR (qPCR) & Whole Genome Sequencing (WGS) with LC-MS/MS Validation |
| ICD-10-CM Code | Z15.09 (Genetic Susceptibility to Other Disease) |
| LOINC Code | 34718-2 (Thrombophilia panel โ Blood) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians